Updated on 12 December 2025
Functional molecules development and synthesis
Project Manager at Sikemia
Grabels, France
About
SIKÉMIA, is a French company with Dual-Skills:
- Strong background for the tailor-made design and scale-up of reactants, linkers, coupling agents.
- High competence in surface functionalization to provide new properties like reactive functions, easy to clean, bio-immobilisation, filler compatibilization… to material surfaces.
You can visit our website http://www.sikemia.com
SiKEMIA can synthesize tailor made functional molecules in the Si, S, P and carbonyle chemistries. Our glasswares equipment allows us to perform syntheses from g to KG scale.
Topic
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-04: Development of novel vaccines for viral pathogens with epidemic potential
Type
- Partner seeks Consortium/Coordinator
Organisation
Similar opportunities
Project cooperation
Advanced Nanoparticle Platforms for Targeted Therapeutics and Gene Delivery
- Partner seeks Consortium/Coordinator
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-15: Scaling up innovation in cardiovascular health
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-04: Development of novel vaccines for viral pathogens with epidemic potential
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions
Paola Astolfi
Associate professor at Università Politecnica delle Marche
Ancona, Italy
Project cooperation
- Partner seeks Consortium/Coordinator
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-04: Development of novel vaccines for viral pathogens with epidemic potential
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions
Helmi Ernandes
Associate Professor in Infectious Diseases at Faculty of Medicine of Tunis
Manouba, Tunisia
Project cooperation
- DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-04: Development of novel vaccines for viral pathogens with epidemic potential
Angelo Raggioli
Head of Technology Development at ReiThera srl
Rome, Italy